Policies for biosimilar uptake in Europe: An overview

Author:

Moorkens EvelienORCID,Vulto Arnold G.,Huys Isabelle,Dylst Pieter,Godman Brian,Keuerleber Simon,Claus Barbara,Dimitrova Maria,Petrova Guenka,Sović-Brkičić Ljiljana,Slabý Juraj,Šebesta Robin,Laius Ott,Karr Allan,Beck Morgane,Martikainen Jaana E.,Selke Gisbert W.,Spillane Susan,McCullagh Laura,Trifirò Gianluca,Vella Bonanno Patricia,Mack Asbjørn,Fogele Antra,Viksna Anita,Władysiuk Magdalena,Mota-Filipe Helder,Meshkov Dmitry,Kalaba Marija,Mencej Bedrač Simona,Fürst Jurij,Zara Corrine,Skiöld Peter,Magnússon Einar,Simoens Steven

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference48 articles.

1. Biosimilar biologic drugs: a new frontier in medical care;DM Geynisman;Postgrad Med,2017

2. Pricing and Reimbursement of Biosimilars in Central and Eastern European Countries;P Kawalec;Front Pharmacol,2017

3. Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use;Official Journal of the European Union,2001

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3